REG - MS International PLC - First Sales of New Land Based Mobile Gun System

MS InternationalAnnouncement

23/12/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221223:nRSW6810Ka&default-theme=true

RNS Number : 6810K  MS International PLC  23 December 2022

 

 

This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014 which is part of UK law by virtue of the European
Union (Withdrawal) Act 2018

 

 

 

23 December 2022

 

MS INTERNATIONAL plc

(the "Company")

 

First Sales of New Land Based Mobile Gun System

 

In the Company's half year results for the period ended 31(st) October 2022,
we made reference to our continuing development of new military products and
that during the period, we launched our first land based mobile gun system
incorporating our unique 'counter-drone' capability, that had already
attracted considerable attention in the international market.

Further to this update, we are pleased to announce that we have signed a
contract with an overseas customer to supply in 2023 a number of land based
mobile gun systems, which are aptly named MSI-DS TERRAHAWK VSHORAD dual feed
weapon systems - mobile air defence. The total contract value to the Company
is £22.4 million and we are aiming to fulfil the contract as soon as
practicable. Revenues under the contract are expected to be recognised during
the 2023 calendar year. This contract represents the Company's first sales of
this new gun system.

 

For further information please contact:

 

MS INTERNATIONAL
plc
                             Tel: +44 (0)13 0232
2133

Michael Bell

 

Shore Capital

Nomad and Broker
                                            Tel: +44
(0)20 7408 4090

Patrick Castle/Daniel Bush

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDKZMZZVZDGZZM